---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-025784"
form_type: "8-K"
ticker: "BBLG"
cik: "0001419554"
company_name: "Bone Biologics Corp"
filed_at: "2021-10-19T23:59:59+00:00"
generated_at: "2026-06-28T19:56:39.108588+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Bone Biologics closes $7.9M public offering, uplists to Nasdaq Capital Market

## Summary
- Completed public offering of 1,510,455 units at $5.25/unit for gross proceeds of $7.9M.
- Each unit consists of one share of common stock and one warrant (exercise $6.30, 5-year term).
- Warrants are immediately exercisable; underwriter has 45-day option for up to 226,568 additional shares/warrants.
- Company effectuated a 1-for-2.5 reverse stock split effective Oct 12, 2021.
- Shares and warrants began trading on Nasdaq Capital Market on Oct 13, 2021 under BBLG and BBLGW.

## SEC filing metadata
- accession: 0001493152-21-025784
- form_type: 8-K
- ticker: BBLG
- cik: 0001419554
- company_name: Bone Biologics Corp
- filed_at: 2021-10-19T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1419554/000149315221025784/0001493152-21-025784-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1419554/000149315221025784/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-025784
- JSON: https://secwatch.observer/filing/0001493152-21-025784.json
- Plain text: https://secwatch.observer/filing/0001493152-21-025784.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.